MITD Company Description
Through its wholly owned subsidiaries, MIT Holding Inc. distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, consults and operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil. MIT's domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.
MITD’s other subsidiaries include LowCountry Compounding Pharmacy and ProVector.
MITD has invested $1M in capital improvements into LowCountry Compounding Pharmacy. With the introduction of robotics, this division now has the growth capabilities to handle in excess of $100M of gross annual sales of pharmaceuticals.
The ProVector® Entobac® Patent Pending was developed by Dr. Tom Kollars at MEVLABS, Inc. to be an economical and environmentally safe “GREEN” device for killing adult mosquitoes. The ProVector Entobac is the first device capable of killing adult mosquitios with Bt biopesticide; which is virtually non-toxic according to the EPA.
One of MITD subsidiaries many products ProVector Entobac was even featured on CNN as a breakthrough Green pesticide. See it here:http://vimeo.com/42477892
MITD Products and Services
MITD distributes wholesale pharmaceuticals in the US and overseas, administers intravenous infusions and, in Georgia, consults and operates ambulatory centers where therapies are administered and sells and rents home medical equipment.
MITD has initiated government contracts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil.
MITD’s domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.
The Company plans to commence rapid growth through a series of acquisitions for each of its divisions. Management is in active negotiations for a number of acquisitions that will grow the Company by adding both products and services that will benefit clients worldwide.
Medical Infusion Technologies
When you or a loved one has been discharged from the hospital or has received special instructions from a physician for continued outpatient care, ask your healthcare provider to refer you to Medical Infusion Technologies. We specialize in offering professional, caring Ambulatory Infusion Therapy, Home Infusion Therapy, Medical Equipment services – including walkers, wheelchairs and respiratory equipment – and much more to residents in Southeast Georgia and the South Carolina Low Country. Medical Infusion Technologies even offers 24/7 on-call nursing, personalized training on select services and equipment and we handle all of your insurance paperwork. When you’re in need of our expert care, choose Medical Infusion Technologies. Ask your healthcare provider to refer you today.
CLICK HERE TO VISIT THE MEDICAL INFUSION TECHNOLOGIES WEB SITE http://medicalinfusion.com/
http://www.mitholdingsinc.com/divisions/medical-infusion-technologies
MITD Key Company Management
William C. Parker, Co-President and Co-Chairman of the Board of Directors
Mr. Parker has served as President, Co-President and Co-Chairman of the Board of Directors of MIT Holding Inc. since its inception in 2006. Mr. Parker has managed MIT since founding the business in 1990. He currently serves as President, Chief Executive Officer and member of the board of directors of MIT Holding Inc.'s two operating subsidiaries. Mr. Parker attended Armstrong State University in Savannah, Georgia and graduated from the American Banking Institute in Savannah Georgia.
Walter H.C. Drakeford, Co-President and Co-Chairman of the Board of Directors
Mr. Drakeford joined MIT Holding, Inc. in 2010 as Co-President and Co-chairman of the Board of Directors. His stellar career includes being the senior managing director of Drakeford & Drakeford for the past 20 years. Since 2007, he has been the director of mergers and acquisitions of AMC Global Communications, Inc. Mr. Drakeford served as chairman of the board for Ebank Financial Services. He has also served on the boards of Netstar-USA Corp. and LaidLaw Transportation as well as serving as an attaché to the White House under Presidents Nixon, Reagan and George H.W. Bush. Mr. Drakeford holds a finance degree from the University of Berlin and a Masters of Business Administration from Heed University. He also holds a law degree from Thomas Jefferson School of Law.
http://www.mitholdingsinc.com/company-overview/management#moreInfo-270
MITD Contact Info
MIT Holding Inc.
351B Commercial Way
Savannah, GA 31406
Website: http://www.mitholdingsinc.com/home-2
Phone: (912) 925-1905
MITD SEC Filings
http://www.otcmarkets.com/stock/MITD/filings
MITD Headlines
http://finance.yahoo.com/q?s=MITD&x=53&y=16
Investigate more about MITD @ http://www.otcmarkets.com/stock/MITD/quote for more due diligence.
$MITD Curaspan Health Group Awards Contract to MIT Holding, Inc. (MITD), Accessing the Central Network for Patient Transitions
ReplyDeleteSAVANNAH, GA -- (Marketwired) -- 03/10/14
MIT Holding, Inc. (OTCQB: MITD) announced today that Curaspan Health Group awarded a "Renewed Annual Referral Central Network for Patient Transitions" contract. This will allow MIT and its future acquisitions to market on a real-time basis the compound pharmaceuticals, infusion services and durable medical equipment directly to the patients of over 5,400 Curaspan medical facilities.
Recognized as the industry leader, Curaspan in 1999 was the first company to automate the on-demand creation of targeted, comprehensive online referral packets. Curaspan connects providers, payers and suppliers via secure electronic patient-transition networks to improve outcomes as patients move between levels of care.
Walter Drakeford, MITD's CEO, stated, "MIT Holding turned to Curaspan because of its one of a kind industry reputation. Curaspan leads its competitors in nearly every category used by KLAS to rate transition planning solutions.
"The alliance is a double win for MIT first our cost to acquire the patient will be one of the lowest in the industry, while increasing staff efficiencies. The training of Curaspan systems only requires 2.5 hours of classroom for staff.
"The second win passes through to the acquisition targets of MIT. Any acquisition doing business in any given geographic location, will be able to market all MIT product lines into every geographic locations MIT Holding is licensed. Creating an 'overnight' product depth and economic edge on their local competitors."
Curaspan Health Group (www.curaspan.com) is a national provider of secure Health Information Exchange and Patient Transition software and services. The company's software and web-based services enable healthcare organizations to increase revenues, improve productivity, and reduce cost by eliminating the paper and manual work-flow steps from the clinical and administrative responsibilities while ensuring regulatory compliance. The company's web-based applications are delivered as Software as a Service (SaaS) to its customers. Its flexible platform and interoperability with the leading HIS vendors (Meditech, McKesson, Cerner, Eclypsis, ACS-Midas+ and Epic) allow for a seamless integration and a rapid, cost effective deployment.
With its focus on customer support, client satisfaction, and strong ROI, Curaspan has realized an industry-leading 98% customer retention rate throughout its ten-year history. Curaspan's client base includes many of the leading health care providers in the country including New York Presbyterian Health System, Dartmouth Hitchcock Alliance, Johns Hopkins Health System, Partners Healthcare, Medstar Health System and Sentara Healthcare System.
For more information, contact Mr. William Nalley, Orsay Groupe, info@orsaygroupe.com, phone 305-790-2688 and/or visit http://www.mitholdingsinc.com/home-2.
http://www.stockwatch.com/News/Item.aspx?bid=U-i1096537-U%3aMITD-20140310&symbol=MITD®ion=U